SICOR Invites You to Join Its First Quarter 2001 Conference Call on the Web

Apr 12, 2001, 01:00 ET from SICOR Inc.

    IRVINE, Calif., April 12 /PRNewswire/ -- In conjunction with SICOR Inc.'s
 (Nasdaq:   SCRI) first quarter 2001 financial results press release, you are
 invited to listen to its conference call that will be broadcast live over the
 Internet on Thursday, April 26, 2001 at 12:00 p.m. Eastern Time.
 
     What:      SICOR Inc. First Quarter Financial Results
 
     When:      12:00 p.m. Eastern on Thursday, April 26, 2001
 
     Where:     http://www.sicorinc.com under "Investor Resources and News"
 
     How:       Live over the Internet -- Simply log on to the web at the
                address above
 
     Contact:   SICOR Investor Relations
                949-455-4879
                ir@gensiasicor.com
 
     If you are unable to participate during the live webcast, the call will be
 archived on the Web site http://www.sicorinc.com for approximately seven days.
 To access the replay, follow the SICOR Inc. link to the Investor Resources web
 page.  From this page you will find a link to the replay under "Conference
 Calls and Presentations" web page.  The Call will also be available until
 1:00 a.m. Eastern Sunday, April 29, 2001 by calling (888) 203-1112, or
 719-457-0820 if from an international phone, with pass code 624542.
     SICOR Inc. is a vertically integrated specialty pharmaceutical company
 with proven expertise in the development, manufacturing and marketing of
 multi-source injectable pharmaceuticals.  With a strategy of combining both
 the production of active pharmaceutical ingredients utilizing chemical
 synthesis or fermentation and state of the art manufacturing facilities,
 SICOR's primary focus is on the worldwide injectable pharmaceutical market,
 which currently includes oncology, anesthesiology, cardiology and other
 therapeutic areas.  SICOR operates several manufacturing facilities in Europe,
 Mexico and the U.S.A., while maintaining the corporate headquarters in Irvine,
 California.
 
 

SOURCE SICOR Inc.
    IRVINE, Calif., April 12 /PRNewswire/ -- In conjunction with SICOR Inc.'s
 (Nasdaq:   SCRI) first quarter 2001 financial results press release, you are
 invited to listen to its conference call that will be broadcast live over the
 Internet on Thursday, April 26, 2001 at 12:00 p.m. Eastern Time.
 
     What:      SICOR Inc. First Quarter Financial Results
 
     When:      12:00 p.m. Eastern on Thursday, April 26, 2001
 
     Where:     http://www.sicorinc.com under "Investor Resources and News"
 
     How:       Live over the Internet -- Simply log on to the web at the
                address above
 
     Contact:   SICOR Investor Relations
                949-455-4879
                ir@gensiasicor.com
 
     If you are unable to participate during the live webcast, the call will be
 archived on the Web site http://www.sicorinc.com for approximately seven days.
 To access the replay, follow the SICOR Inc. link to the Investor Resources web
 page.  From this page you will find a link to the replay under "Conference
 Calls and Presentations" web page.  The Call will also be available until
 1:00 a.m. Eastern Sunday, April 29, 2001 by calling (888) 203-1112, or
 719-457-0820 if from an international phone, with pass code 624542.
     SICOR Inc. is a vertically integrated specialty pharmaceutical company
 with proven expertise in the development, manufacturing and marketing of
 multi-source injectable pharmaceuticals.  With a strategy of combining both
 the production of active pharmaceutical ingredients utilizing chemical
 synthesis or fermentation and state of the art manufacturing facilities,
 SICOR's primary focus is on the worldwide injectable pharmaceutical market,
 which currently includes oncology, anesthesiology, cardiology and other
 therapeutic areas.  SICOR operates several manufacturing facilities in Europe,
 Mexico and the U.S.A., while maintaining the corporate headquarters in Irvine,
 California.
 
 SOURCE  SICOR Inc.

RELATED LINKS

http://www.gensia.com/investrel.html